MUC5AC and neoplasm: There is increasing evidence between aberrant glycosylations or expression of mucin peptides and neoplasms, such as MUC1, MUC2, MUC5AC in pancreatic neoplasm; MUC1, MUC4 in Gastrointestinal neoplasms [6].